Global Therapeutic Nuclear Medicines Supply, Demand and Key Producers, 2024-2030
Page: 133
Published Date: 21 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Therapeutic Nuclear Medicines market size is expected to reach $ 5230.4 million by 2030, rising at a market growth of 17.2% CAGR during the forecast period (2024-2030).
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report studies the global Therapeutic Nuclear Medicines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Therapeutic Nuclear Medicines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Nuclear Medicines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Therapeutic Nuclear Medicines total production and demand, 2019-2030, (K Units)
Global Therapeutic Nuclear Medicines total production value, 2019-2030, (USD Million)
Global Therapeutic Nuclear Medicines production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Therapeutic Nuclear Medicines consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Therapeutic Nuclear Medicines domestic production, consumption, key domestic manufacturers and share
Global Therapeutic Nuclear Medicines production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Therapeutic Nuclear Medicines production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Therapeutic Nuclear Medicines production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Therapeutic Nuclear Medicines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus and Acrotech Biopharma., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Nuclear Medicines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Therapeutic Nuclear Medicines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Therapeutic Nuclear Medicines Market, Segmentation by Type
Radium-223
Lutetium-177
Iodine-131
Other
Global Therapeutic Nuclear Medicines Market, Segmentation by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Companies Profiled:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Key Questions Answered
1. How big is the global Therapeutic Nuclear Medicines market?
2. What is the demand of the global Therapeutic Nuclear Medicines market?
3. What is the year over year growth of the global Therapeutic Nuclear Medicines market?
4. What is the production and production value of the global Therapeutic Nuclear Medicines market?
5. Who are the key producers in the global Therapeutic Nuclear Medicines market?
Table of Contents
1 Supply Summary
1.1 Therapeutic Nuclear Medicines Introduction
1.2 World Therapeutic Nuclear Medicines Supply & Forecast
1.2.1 World Therapeutic Nuclear Medicines Production Value (2019 & 2023 & 2030)
1.2.2 World Therapeutic Nuclear Medicines Production (2019-2030)
1.2.3 World Therapeutic Nuclear Medicines Pricing Trends (2019-2030)
1.3 World Therapeutic Nuclear Medicines Production by Region (Based on Production Site)
1.3.1 World Therapeutic Nuclear Medicines Production Value by Region (2019-2030)
1.3.2 World Therapeutic Nuclear Medicines Production by Region (2019-2030)
1.3.3 World Therapeutic Nuclear Medicines Average Price by Region (2019-2030)
1.3.4 North America Therapeutic Nuclear Medicines Production (2019-2030)
1.3.5 Europe Therapeutic Nuclear Medicines Production (2019-2030)
1.3.6 China Therapeutic Nuclear Medicines Production (2019-2030)
1.3.7 India Therapeutic Nuclear Medicines Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Nuclear Medicines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Therapeutic Nuclear Medicines Major Market Trends
2.1 World Therapeutic Nuclear Medicines Demand (2019-2030)
2.2 World Therapeutic Nuclear Medicines Consumption by Region
2.2.1 World Therapeutic Nuclear Medicines Consumption by Region (2019-2024)
2.2.2 World Therapeutic Nuclear Medicines Consumption Forecast by Region (2025-2030)
2.3 United States Therapeutic Nuclear Medicines Consumption (2019-2030)
2.4 China Therapeutic Nuclear Medicines Consumption (2019-2030)
2.5 Europe Therapeutic Nuclear Medicines Consumption (2019-2030)
2.6 Japan Therapeutic Nuclear Medicines Consumption (2019-2030)
2.7 South Korea Therapeutic Nuclear Medicines Consumption (2019-2030)
2.8 ASEAN Therapeutic Nuclear Medicines Consumption (2019-2030)
2.9 India Therapeutic Nuclear Medicines Consumption (2019-2030)
3.1 World Therapeutic Nuclear Medicines Production Value by Manufacturer (2019-2024)
3.2 World Therapeutic Nuclear Medicines Production by Manufacturer (2019-2024)
3.3 World Therapeutic Nuclear Medicines Average Price by Manufacturer (2019-2024)
3.4 Therapeutic Nuclear Medicines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Therapeutic Nuclear Medicines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Therapeutic Nuclear Medicines in 2023
3.5.3 Global Concentration Ratios (CR8) for Therapeutic Nuclear Medicines in 2023
3.6 Therapeutic Nuclear Medicines Market: Overall Company Footprint Analysis
3.6.1 Therapeutic Nuclear Medicines Market: Region Footprint
3.6.2 Therapeutic Nuclear Medicines Market: Company Product Type Footprint
3.6.3 Therapeutic Nuclear Medicines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Therapeutic Nuclear Medicines Production Value Comparison
4.1.1 United States VS China: Therapeutic Nuclear Medicines Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Therapeutic Nuclear Medicines Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Therapeutic Nuclear Medicines Production Comparison
4.2.1 United States VS China: Therapeutic Nuclear Medicines Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Therapeutic Nuclear Medicines Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Therapeutic Nuclear Medicines Consumption Comparison
4.3.1 United States VS China: Therapeutic Nuclear Medicines Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Therapeutic Nuclear Medicines Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Therapeutic Nuclear Medicines Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Therapeutic Nuclear Medicines Production Value (2019-2024)
4.4.3 United States Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024)
4.5 China Based Therapeutic Nuclear Medicines Manufacturers and Market Share
4.5.1 China Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Therapeutic Nuclear Medicines Production Value (2019-2024)
4.5.3 China Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024)
4.6 Rest of World Based Therapeutic Nuclear Medicines Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024)
5.1 World Therapeutic Nuclear Medicines Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Radium-223
5.2.2 Lutetium-177
5.2.3 Iodine-131
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Therapeutic Nuclear Medicines Production by Type (2019-2030)
5.3.2 World Therapeutic Nuclear Medicines Production Value by Type (2019-2030)
5.3.3 World Therapeutic Nuclear Medicines Average Price by Type (2019-2030)
6.1 World Therapeutic Nuclear Medicines Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Thyroid
6.2.2 Bone Metastasis
6.2.3 Lymphoma
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Therapeutic Nuclear Medicines Production by Application (2019-2030)
6.3.2 World Therapeutic Nuclear Medicines Production Value by Application (2019-2030)
6.3.3 World Therapeutic Nuclear Medicines Average Price by Application (2019-2030)
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Therapeutic Nuclear Medicines Product and Services
7.1.4 Novartis AG Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Therapeutic Nuclear Medicines Product and Services
7.2.4 Bayer Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Details
7.3.2 China Isotope & Radiation Major Business
7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
7.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 China Isotope & Radiation Recent Developments/Updates
7.3.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.4 Q BioMed
7.4.1 Q BioMed Details
7.4.2 Q BioMed Major Business
7.4.3 Q BioMed Therapeutic Nuclear Medicines Product and Services
7.4.4 Q BioMed Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Q BioMed Recent Developments/Updates
7.4.6 Q BioMed Competitive Strengths & Weaknesses
7.5 Curium Pharmaceuticals
7.5.1 Curium Pharmaceuticals Details
7.5.2 Curium Pharmaceuticals Major Business
7.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
7.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Curium Pharmaceuticals Recent Developments/Updates
7.5.6 Curium Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Jubilant DraxImage
7.6.1 Jubilant DraxImage Details
7.6.2 Jubilant DraxImage Major Business
7.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
7.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Jubilant DraxImage Recent Developments/Updates
7.6.6 Jubilant DraxImage Competitive Strengths & Weaknesses
7.7 Dongcheng
7.7.1 Dongcheng Details
7.7.2 Dongcheng Major Business
7.7.3 Dongcheng Therapeutic Nuclear Medicines Product and Services
7.7.4 Dongcheng Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Dongcheng Recent Developments/Updates
7.7.6 Dongcheng Competitive Strengths & Weaknesses
7.8 Lantheus
7.8.1 Lantheus Details
7.8.2 Lantheus Major Business
7.8.3 Lantheus Therapeutic Nuclear Medicines Product and Services
7.8.4 Lantheus Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Lantheus Recent Developments/Updates
7.8.6 Lantheus Competitive Strengths & Weaknesses
7.9 Acrotech Biopharma.
7.9.1 Acrotech Biopharma. Details
7.9.2 Acrotech Biopharma. Major Business
7.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
7.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Acrotech Biopharma. Recent Developments/Updates
7.9.6 Acrotech Biopharma. Competitive Strengths & Weaknesses
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Details
7.10.2 Progenics Pharmaceuticals Major Business
7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
7.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Progenics Pharmaceuticals Recent Developments/Updates
7.10.6 Progenics Pharmaceuticals Competitive Strengths & Weaknesses
7.11 International Isotopes
7.11.1 International Isotopes Details
7.11.2 International Isotopes Major Business
7.11.3 International Isotopes Therapeutic Nuclear Medicines Product and Services
7.11.4 International Isotopes Therapeutic Nuclear Medicines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 International Isotopes Recent Developments/Updates
7.11.6 International Isotopes Competitive Strengths & Weaknesses
8.1 Therapeutic Nuclear Medicines Industry Chain
8.2 Therapeutic Nuclear Medicines Upstream Analysis
8.2.1 Therapeutic Nuclear Medicines Core Raw Materials
8.2.2 Main Manufacturers of Therapeutic Nuclear Medicines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Therapeutic Nuclear Medicines Production Mode
8.6 Therapeutic Nuclear Medicines Procurement Model
8.7 Therapeutic Nuclear Medicines Industry Sales Model and Sales Channels
8.7.1 Therapeutic Nuclear Medicines Sales Model
8.7.2 Therapeutic Nuclear Medicines Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Therapeutic Nuclear Medicines Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Therapeutic Nuclear Medicines Production Value by Region (2019-2024) & (USD Million)
Table 3. World Therapeutic Nuclear Medicines Production Value by Region (2025-2030) & (USD Million)
Table 4. World Therapeutic Nuclear Medicines Production Value Market Share by Region (2019-2024)
Table 5. World Therapeutic Nuclear Medicines Production Value Market Share by Region (2025-2030)
Table 6. World Therapeutic Nuclear Medicines Production by Region (2019-2024) & (K Units)
Table 7. World Therapeutic Nuclear Medicines Production by Region (2025-2030) & (K Units)
Table 8. World Therapeutic Nuclear Medicines Production Market Share by Region (2019-2024)
Table 9. World Therapeutic Nuclear Medicines Production Market Share by Region (2025-2030)
Table 10. World Therapeutic Nuclear Medicines Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Therapeutic Nuclear Medicines Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Therapeutic Nuclear Medicines Major Market Trends
Table 13. World Therapeutic Nuclear Medicines Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Therapeutic Nuclear Medicines Consumption by Region (2019-2024) & (K Units)
Table 15. World Therapeutic Nuclear Medicines Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Therapeutic Nuclear Medicines Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Therapeutic Nuclear Medicines Producers in 2023
Table 18. World Therapeutic Nuclear Medicines Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Therapeutic Nuclear Medicines Producers in 2023
Table 20. World Therapeutic Nuclear Medicines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Therapeutic Nuclear Medicines Company Evaluation Quadrant
Table 22. World Therapeutic Nuclear Medicines Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Therapeutic Nuclear Medicines Production Site of Key Manufacturer
Table 24. Therapeutic Nuclear Medicines Market: Company Product Type Footprint
Table 25. Therapeutic Nuclear Medicines Market: Company Product Application Footprint
Table 26. Therapeutic Nuclear Medicines Competitive Factors
Table 27. Therapeutic Nuclear Medicines New Entrant and Capacity Expansion Plans
Table 28. Therapeutic Nuclear Medicines Mergers & Acquisitions Activity
Table 29. United States VS China Therapeutic Nuclear Medicines Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Therapeutic Nuclear Medicines Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Therapeutic Nuclear Medicines Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Therapeutic Nuclear Medicines Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Therapeutic Nuclear Medicines Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Therapeutic Nuclear Medicines Production Market Share (2019-2024)
Table 37. China Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Therapeutic Nuclear Medicines Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Therapeutic Nuclear Medicines Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Therapeutic Nuclear Medicines Production Market Share (2019-2024)
Table 42. Rest of World Based Therapeutic Nuclear Medicines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production Market Share (2019-2024)
Table 47. World Therapeutic Nuclear Medicines Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Therapeutic Nuclear Medicines Production by Type (2019-2024) & (K Units)
Table 49. World Therapeutic Nuclear Medicines Production by Type (2025-2030) & (K Units)
Table 50. World Therapeutic Nuclear Medicines Production Value by Type (2019-2024) & (USD Million)
Table 51. World Therapeutic Nuclear Medicines Production Value by Type (2025-2030) & (USD Million)
Table 52. World Therapeutic Nuclear Medicines Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Therapeutic Nuclear Medicines Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Therapeutic Nuclear Medicines Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Therapeutic Nuclear Medicines Production by Application (2019-2024) & (K Units)
Table 56. World Therapeutic Nuclear Medicines Production by Application (2025-2030) & (K Units)
Table 57. World Therapeutic Nuclear Medicines Production Value by Application (2019-2024) & (USD Million)
Table 58. World Therapeutic Nuclear Medicines Production Value by Application (2025-2030) & (USD Million)
Table 59. World Therapeutic Nuclear Medicines Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Therapeutic Nuclear Medicines Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Therapeutic Nuclear Medicines Product and Services
Table 64. Novartis AG Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Therapeutic Nuclear Medicines Product and Services
Table 70. Bayer Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 74. China Isotope & Radiation Major Business
Table 75. China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
Table 76. China Isotope & Radiation Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. China Isotope & Radiation Recent Developments/Updates
Table 78. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 79. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 80. Q BioMed Major Business
Table 81. Q BioMed Therapeutic Nuclear Medicines Product and Services
Table 82. Q BioMed Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Q BioMed Recent Developments/Updates
Table 84. Q BioMed Competitive Strengths & Weaknesses
Table 85. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Curium Pharmaceuticals Major Business
Table 87. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 88. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Curium Pharmaceuticals Recent Developments/Updates
Table 90. Curium Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 92. Jubilant DraxImage Major Business
Table 93. Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
Table 94. Jubilant DraxImage Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Jubilant DraxImage Recent Developments/Updates
Table 96. Jubilant DraxImage Competitive Strengths & Weaknesses
Table 97. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 98. Dongcheng Major Business
Table 99. Dongcheng Therapeutic Nuclear Medicines Product and Services
Table 100. Dongcheng Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Dongcheng Recent Developments/Updates
Table 102. Dongcheng Competitive Strengths & Weaknesses
Table 103. Lantheus Basic Information, Manufacturing Base and Competitors
Table 104. Lantheus Major Business
Table 105. Lantheus Therapeutic Nuclear Medicines Product and Services
Table 106. Lantheus Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Lantheus Recent Developments/Updates
Table 108. Lantheus Competitive Strengths & Weaknesses
Table 109. Acrotech Biopharma. Basic Information, Manufacturing Base and Competitors
Table 110. Acrotech Biopharma. Major Business
Table 111. Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
Table 112. Acrotech Biopharma. Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Acrotech Biopharma. Recent Developments/Updates
Table 114. Acrotech Biopharma. Competitive Strengths & Weaknesses
Table 115. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Progenics Pharmaceuticals Major Business
Table 117. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 118. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Progenics Pharmaceuticals Recent Developments/Updates
Table 120. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 121. International Isotopes Major Business
Table 122. International Isotopes Therapeutic Nuclear Medicines Product and Services
Table 123. International Isotopes Therapeutic Nuclear Medicines Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Therapeutic Nuclear Medicines Upstream (Raw Materials)
Table 125. Therapeutic Nuclear Medicines Typical Customers
Table 126. Therapeutic Nuclear Medicines Typical Distributors
List of Figure
Figure 1. Therapeutic Nuclear Medicines Picture
Figure 2. World Therapeutic Nuclear Medicines Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Therapeutic Nuclear Medicines Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Therapeutic Nuclear Medicines Production (2019-2030) & (K Units)
Figure 5. World Therapeutic Nuclear Medicines Average Price (2019-2030) & (USD/Unit)
Figure 6. World Therapeutic Nuclear Medicines Production Value Market Share by Region (2019-2030)
Figure 7. World Therapeutic Nuclear Medicines Production Market Share by Region (2019-2030)
Figure 8. North America Therapeutic Nuclear Medicines Production (2019-2030) & (K Units)
Figure 9. Europe Therapeutic Nuclear Medicines Production (2019-2030) & (K Units)
Figure 10. China Therapeutic Nuclear Medicines Production (2019-2030) & (K Units)
Figure 11. India Therapeutic Nuclear Medicines Production (2019-2030) & (K Units)
Figure 12. Therapeutic Nuclear Medicines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 15. World Therapeutic Nuclear Medicines Consumption Market Share by Region (2019-2030)
Figure 16. United States Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 17. China Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 18. Europe Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 19. Japan Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 20. South Korea Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 22. India Therapeutic Nuclear Medicines Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Therapeutic Nuclear Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Therapeutic Nuclear Medicines Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Therapeutic Nuclear Medicines Markets in 2023
Figure 26. United States VS China: Therapeutic Nuclear Medicines Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Therapeutic Nuclear Medicines Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Therapeutic Nuclear Medicines Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Therapeutic Nuclear Medicines Production Market Share 2023
Figure 30. China Based Manufacturers Therapeutic Nuclear Medicines Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Therapeutic Nuclear Medicines Production Market Share 2023
Figure 32. World Therapeutic Nuclear Medicines Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Therapeutic Nuclear Medicines Production Value Market Share by Type in 2023
Figure 34. Radium-223
Figure 35. Lutetium-177
Figure 36. Iodine-131
Figure 37. Other
Figure 38. World Therapeutic Nuclear Medicines Production Market Share by Type (2019-2030)
Figure 39. World Therapeutic Nuclear Medicines Production Value Market Share by Type (2019-2030)
Figure 40. World Therapeutic Nuclear Medicines Average Price by Type (2019-2030) & (USD/Unit)
Figure 41. World Therapeutic Nuclear Medicines Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Therapeutic Nuclear Medicines Production Value Market Share by Application in 2023
Figure 43. Thyroid
Figure 44. Bone Metastasis
Figure 45. Lymphoma
Figure 46. Other
Figure 47. World Therapeutic Nuclear Medicines Production Market Share by Application (2019-2030)
Figure 48. World Therapeutic Nuclear Medicines Production Value Market Share by Application (2019-2030)
Figure 49. World Therapeutic Nuclear Medicines Average Price by Application (2019-2030) & (USD/Unit)
Figure 50. Therapeutic Nuclear Medicines Industry Chain
Figure 51. Therapeutic Nuclear Medicines Procurement Model
Figure 52. Therapeutic Nuclear Medicines Sales Model
Figure 53. Therapeutic Nuclear Medicines Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis AG Bayer China Isotope & Radiation Q BioMed Curium Pharmaceuticals Jubilant DraxImage Dongcheng Lantheus Acrotech Biopharma. Progenics Pharmaceuticals International Isotopes
Related Reports
18 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
